The findings of a study in the Journal of Clinical Psychiatry suggest that the presence of certain symptoms in a cluster referred to as “sluggish cognitive tempo” may predict the efficacy of methylphenidate, the most commonly prescribed medication for attention-deficit/hyperactivity disorder (ADHD) in the world.